CHARMM Force Field Parameterization of Peroxisome Proliferator-Activated Receptor γ Ligands

The peroxisome proliferator-activated receptor γ (PPARγ) ligands are important therapeutic drugs for the treatment of type 2 diabetes, obesity and cardiovascular diseases. In particular, partial agonists and non-agonists are interesting targets to reduce glucose levels, presenting few side effects i...

Descripción completa

Detalles Bibliográficos
Autores principales: Mottin, Melina, Souza, Paulo C. T., Ricci, Clarisse G., Skaf, Munir S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5297650/
https://www.ncbi.nlm.nih.gov/pubmed/28025495
http://dx.doi.org/10.3390/ijms18010015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5297650/
https://www.ncbi.nlm.nih.gov/pubmed/28025495
http://dx.doi.org/10.3390/ijms18010015

Ejemplares similares